• Doctor of Medicine (MD), Tehran, Iran
• Clinical Internship, Tehran-Iran: Internal medicine, infectious diseases, public health, general surgery, emergency medicine, pediatrics, OBGYN, cariology, psychiatry, ENT, and ophthalmology

Post Graduate Education and Training

• 2022 – 2024:  Postdoctoral Research Fellowship, Department of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore, Maryland
• 2024 – 2026:  Postdoctoral Research Fellowship, Department of Epidemiology, Johns Hopkins Bloomberg School of Public Health, Baltimore, Maryland
• 2025 – 2026:  Clinical Services Shadowing / Observership, General Internal Medicine and Infectious Disease, Johns Hopkins Hospital, Baltimore, Maryland
• 2026 – Current:  Clinical Research Fellowship, Department of Anesthesiology, University of Maryland School of Medicine, Baltimore, Maryland

1. Falade-Nwulia O, Price J, Feld J, et al., Rapid hepatitis C test and treat with peer support at opioid treatment programs (RAPID HCV): a hybrid effectiveness-implementation type 1 randomized control trial, The Lancet Regional Health – Americas (2026) doi.org/10.1016/j.lana.2026.101439
2. Karimi-Sari H, Lucas G, Zook K, Weir B, Landry M, Sherman S, Page K, Falade-Nwulia O, Hazardous Alcohol Use and Its Effect on Direct-Acting Antiviral Therapy Initiation among People with Active Injection Drug Use and Current Hepatitis C Infection, Viruses Sep 2024. doi.org/10.3390/v16091416
3. Karimi-Sari H, Piggott D, Scully E, Ward K, Sutcliffe C, Sulkowski M, Falade-Nwulia O, Changes in inflammatory cytokines after chronic hepatitis C treatment among people living with HIV, Open Forum Infectious Diseases. 2024 11 (1). doi.org/10.1093/ofid/ofad623
4. Karimi-Sari H, Hosseini MA, Nikjoo N, Bagheri Baghdasht MS, Alavian SM, Patient-reported Outcomes of Sleep, Mood, and Quality of Life After Treatment of Chronic Hepatitis C Infection Using Direct-Acting Antiviral Agents. Clin Microbiol Infect. 2020;27(20). doi.org/10.1016/j.cmi.2020.04.029
5. Madani SJ, Araste Fard F, Karimi-Sari H*, Khosravi MH, Delavari A, Comparison of acid–base and electrolyte imbalances between normal saline and 1.4% sodium bicarbonate intravenous fluids therapy during cervical and lumbar laminectomy, Polish Annals of Medicine, 2017, doi.org/10.1016/j.poamed.2016.03.005
6. Karimi-Sari H, Faraji M, Torabi SM, Asjodi G. Success rate and complications of internal jugular vein catheterization with and without ultrasonography guide. Nursing and Midwifery Studies. 2014;3(4). pubmed.ncbi.nlm.nih.gov/25741514/

Original research

1. Campoverde Reyes K, Guevara J, Karimi-Sari H, Goyes D, Lapumnuaypol K, et al., Differential NMR Lipoprotein Profiles and Prediction of Insulin Resistance and Metabolic Syndrome by LP-IR Among Adult Chronic Hepatitis B Patients, J. Clinical Medicine. 2025, 14(20), 7405; doi.org/10.3390/jcm14207405
2. Falade-Nwulia O, Ward K, Wagner K, Karimi-Sari H, Hsu J, Sulkowski M, Latkin C, Nwulia E, Loneliness and fearfulness are associated with non-fatal drug overdose among people who inject drugs, PLOS One, February 21, 2024. doi.org/10.1371/journal.pone.0297209
3. Karimi-Sar H, Sharafi H, Rezaee-Zavareh MS, Alavian SM. Harm reduction during the COVID-19 outbreak in Iran. The Lancet Psychiatry. 2020. doi.org/10.1016/S2215-0366(20)30306-0
4. Ghadiany M, Tabarraee M, Salari S, Haghighi S, Rezvani H, Ghasemi SN, Karimi-Sari H. Adding Oral Pioglitazone to Standard Induction Chemotherapy of Acute Myeloid Leukemia: A Randomized Clinical Trial. Clinical Lymphoma Myeloma and Leukemia. 2019;19(4). doi.org/10.1016/j.clml.2019.01.006
5. Khosravi A, Karimi‐Sari H*, Abedi‐Andani M, et al. Acute changes in cardiac function by direct acting antiviral therapy for hepatitis C− infected patients with thalassemia. Journal of medical virology. 2018. doi.org/10.1002/jmv.25314
6. Karimi-Sari H, Tajik M, Bayatpoor ME, Sharafi H, Alavian SM. Public awareness campaign and knowledge of Iranian (bio)medical students regarding hepatitis B and C infections. Hepatitis Monthly. 2017;17(5). doi.org/10.5812/hepatmon.45929
7. Karimi-Sari H, Bayatpoor ME, Khotbesara MA, et al. Knowledge, attitude, and practice of Iranian health sciences students regarding hepatitis B and C virus infections: A national survey. American journal of infection control. 2017;45(11). doi.org/10.1016/j.ajic.2017.07.012
8. Niroomand M, Ghasemi SN, Karimi-Sari H*, Khosravi MH. Knowledge, Attitude, and Practice of Iranian Internists Regarding Diabetes: A Cross Sectional Study. Diabetes & metabolism journal. 2017;41(3). doi.org/10.4093/dmj.2017.41.3.179
9. Ajudani R, Rezaee-Zavareh MS, Karimi-Sari H, Safiabadi M, Dolatimehr F, Okhovatian M, et al. Glycosylated haemoglobin and coronary atherosclerosis in non-diabetic patients: is it a prognostic factor? Acta Cardiologica. 2017;72(5). doi.org/10.1080/00015385.2017.1306309
10. Akhavan A, Jafari SM, Khosravi MH, Khajehpour H, Karimi‐Sari H. Reliability of fine‐needle aspiration and ultrasound‐based characteristics of thyroid nodules for diagnosing malignancy in Iranian patients. Diagnostic cytopathology. 2016. doi.org/10.1002/dc.23430
11. Sadeghi-Ghahrody M, Yousefi-Malekshah SH, Karimi-Sari H*, et al. Bleeding after tooth extraction in patients taking aspirin and clopidogrel (Plavix®) compared with healthy controls. British Journal of Oral and Maxillofacial Surgery. 2016;54(5). doi.org/10.1016/j.bjoms.2016.02.036
12. Jafari FM, Alipour PS, Nafar M, Ghaffari-Rahbar M, Omidi F, Karimi-Sari H*. Serum Troponin I Level for Diagnosis of Acute Coronary Syndrome in Patients with Chronic Kidney Disease. Iranian journal of kidney diseases. 2016;10(1). pubmed.ncbi.nlm.nih.gov/26837675/
13. Akhavan A, Karimi‐Sari H*, Khosravi MH, Arefzadeh E, Yavarahmadi M. Comparing the effects of ketotifen fumarate eye drops and ketotifen oral pills on symptom severity and quality of life in patients with allergic rhinitis: a double‐blind randomized clinical trial. International forum of allergy & rhinology. 2015;5(5):386-91. doi.org/10.1002/alr.21491
14. Lak M, Yousefi A, Karimi-Sari H, Saghafinia M. Analgesic Effect of Clonidine Added to Bupivacaine in Spinal Anesthesia for Cruciate Ligament Repair. Trauma Mon. 2015 May;20(2):e17879. pmc.ncbi.nlm.nih.gov/articles/PMC4538728/

Editorials/letters

1. Karimi-Sari H, Falade-Nwulia O, Hepatitis Delta Virus Infection in the United States: If you seek, you may find, Digestive Diseases and Science, 2023. doi.org/10.1007/s10620-023-07961-x [Invited Editorial]
2. Karimi-Sari H, Rezaee-Zavareh MS. Altered hepatitis C testing and treatment beyond the COVID-19 pandemic. Public Health. 2022. doi.org/10.1016/j.puhe.2022.03.018
3. Karimi-Sari H, Rezaee-Zavareh MS. Nucleo(s)tide analogue withdrawal in chronic hepatitis B virus infection: Beyond the HBsAg loss. Digestive and Liver Diseases. 2022. doi.org/10.1016/j.dld.2022.04.004
4. Karimi-Sari H, Rezaee-Zavareh MS. Further Risk Factors for Developing Non-alcoholic Fatty Liver Disease in Female Healthcare Workers. Clinical Nutrition. 2022. doi.org/10.1016/j.clnu.2022.03.015
5. Rezaee-Zavareh MS, Karimi-Sari H, Alavian SM. Iran, sanctions, and research collaborations. THE LANCET. 2016;387. doi.org/10.1016/S0140-6736(15)01295-7
6. Karimi-Sar H, Rezaee-Zavareh MS. COVID-19 and Viral Hepatitis Elimination Programs: Are We Stepping Backward? Liver International 2020 Apr 22. doi.org/10.1111/liv.14486
7. Karimi-Sari H, Tajik M, Bayatpoor ME, Alavian SM. Increasing the awareness of the general population: an important step in elimination programs of viral hepatitis. American journal of gastroenterology. 2017;112(2). doi.org/10.1038/ajg.2016.534
8. Karimi-Sari H, Rezaee-Zavareh MS. Non-atherosclerotic Cardiac Manifestations of Chronic Hepatitis C Virus Infection in the Era of Direct-Acting Antiviral Agents. Atherosclerosis 2020;298. doi.org10.1016/j.atherosclerosis.2020.02.021
9. Karimi-Sari H, Akhavan-Moghadam J. Barriers for ultrasound-guided central venous catheterization in Iran. Journal of critical care. 2016 Dec 1;36:289. doi.org/10.1016/j.jcrc.2016.08.015
10. Nima M, Karimi-Sari H, Alavian SM. Art and viral hepatitis elimination programs. Journal of virus eradication. 2018;4(1). doi.org/10.1016/S2055-6640(20)30244-2
11. Karimi-Sari H, Bayatpoor M, Alavian S. Awareness Campaign in (bio) Medical Students in Iran: a model for increasing the knowledge regarding hepatitis B and C. Clinical Microbiology and Infection. 2017;23(6). doi.org/10.1016/j.cmi.2016.11.022
12. Karimi-Sari H, Rezaee-Zavareh MS, Citation metrics for appraising scientists: misuse, gaming and proper use. Med J Australia. 2020. doi.org/10.5694/mja2.50739
13. Rezaee-Zavareh MS, Karimi-Sar H*. Effect of Published Papers by the Institute for Health Metrics and Evaluation on the Impact Factor of The Lancet Journal. J Investigative Medicine. 2020 May 23. doi.org/10.1136/jim-2020-001398
14. Karimi-Sari H, Rezaee-Zavareh MS, Alavian SM. Street and labour children; special group for elimination of viral hepatitis in Iran. Sexually transmitted infections. 2017;93(1). doi.org/10.1136/sextrans-2016-052890
15. Rezaee-Zavareh MS, Karimi-Sari H*. How Often Do the Iranian Medical Journal Editors-in-Chief Publish in Their Own Journals? Iranian J Public Health, 2020 Jul;49(7). doi.org/10.18502/ijph.v49i7.3592
16. Karimi-Sari H. Authors’ reply on the ’glycosylated haemoglobin and coronary atherosclerosis in non-diabetic patients: is it a prognostic factor?’. Acta Cardiologica. 2018;73(2):214-. doi.org/10.1080/00015385.2017.1384184
17. Karimi-Sari H, Alavian S. Needlestick injury against viral hepatitis elimination. Journal of Hospital Infection.2017;96(4):398. doi.org/10.1016/j.jhin.2017.04.024
18. Karimi‐Sari H, Ghafari Z, Alavian SM. Hepatitis C screening in patients with oral lichen planus. Journal of investigative and clinical dentistry. 2018. doi.org/10.1111/jicd.12350
19. Sharafi H, Karimi‐Sari H, Alavian SM. The high‐diagnostic characteristics of HBsAg level in differentiation of hepatitis B clinical presentations: Myth or truth? Liver International. 2017;37(4):620-1. doi.org/10.1111/liv.13259
20. Karimi-Sari H, Rezaee-Zavareh M. Confounders for bleeding. British Dental Journal. 2016;220(12):611-. doi.org/10.1038/sj.bdj.2016.431
21. Karimi-Sari H, Nikjoo N. Central Venous Cannulation of the Internal Jugular Vein Both With and Without Ultrasound Guidance in Iran. Anesth Pain Med. 2016 Jul 26;6(5):e39256. pmc.ncbi.nlm.nih.gov/articles/PMC5101422/

Systematic Reviews and Meta-analyses

1. Rezaee-Zavareh MS, Karimi-Sari H, Roudsari P, et al., Antibiotic Use Linked to Worse Outcomes in Gastrointestinal and Liver Cancer Patients on Immune Checkpoint Inhibitors: A Meta-Analysis, The American Journal of Gastroenterology (2026) doi.org/10.14309/ajg.0000000000003956
2. Duan Z, Verinumbe T, Karimi-Sari H, Lee G, Agee T, Latkin C, Falade-Nwulia O, Effectiveness of Peer Recovery Support Services for Substance Use Disorders: A Systematic Review of Healthcare Utilization, Behavioral Health, and Engagement Outcomes, Drug and Alcohol Dependence, 2026, doi.org/10.1016/j.drugalcdep.2026.113290
3. Karimi-Sari H, Rezaee-Zavareh MS, Falade-Nwulia O, Lim JK. Non-responders to sofosbuvir/velpatasvir/voxilaprevir in the treatment of chronic hepatitis C infection. Journal of Hepatology. 2022. doi.org/10.1016/j.jhep.2022.06.024
4. Kaur SP, Talat A, Karimi-Sari H, Grees A, Chen HW, Lau DTY, Catana AM. Hepatocellular Carcinoma in Hepatitis B Virus-Infected Patients and the Role of Hepatitis B Surface Antigen (HBsAg). J Clin Med. 2022 Feb 21;11(4):1126. doi.org/10.3390/jcm11041126
5. Alavian SM, Dolatimehr F, Sharafi H, Safi-Abadi M, Rezaee-Zavareh MS, Bayatpour ME, Karimi-Sari H, Mohazzab-Torabi S. Treatment of HCV Infection with Direct-acting Antiviral Agents in Patients with HIV/HCV Co-infection: A Systematic Review. Hepatitis Monthly. 2018 Dec 1;18(12). doi.org/10.5812/hepatmon.82971
6. Dolatimehr F, Karimi-Sari H, Rezaee-Zavareh MS, et al. Combination of sofosbuvir, pegylated-interferon and ribavirin for treatment of hepatitis C virus genotype-1 infection: a systematic review and meta-analysis. DARU journal of pharmaceutical sciences. 2017 Dec;25(1):11. pubmed.ncbi.nlm.nih.gov/28427463/
7. Rezaee-Zavareh MS, Hadi R, Karimi-Sari H, Khosravi MH, Ajudani R, Dolatimehr F, et al. Occult HCV Infection: The Current State of Knowledge. Iranian Red Crescent Medical Journal. 2015;17(11). pubmed.ncbi.nlm.nih.gov/26734487/
8. Rezaee-Zavareh MS, Karimi-Sari H, Dolatimehr F, Alavian SM. Hepatitis A Virus Infection, Vaccination and Iranian Healthcare Workers. Hepatitis monthly. 2015;15(12):e35238. ncbi.nlm.nih.gov/pmc/articles/PMC4779254/

Global Burden of Diseases (GBD) Collaborations

1. GBD 2016 Stroke Collaborators. Global, regional, and national burden of stroke, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016. The Lancet Neurology, 2019. doi.org/10.1016/S1474-4422(19)30034-1
2. GBD 2017 Causes of Death Collaborators. Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 2017. doi.org/10.1016/S0140-6736(18)32203-7
3. GBD 2017 Mortality Collaborators. Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017. The Lancet, 2017. doi.org/10.1016/S0140-6736(18)31891-9
4. GBD 2017 SDG Collaborators. Measuring progress from 1990 to 2017 and projecting attainment to 2030 of the health-related Sustainable Development Goals for 195 countries and territories: a systematic analysis for the Global Burden of Disease Study 2017 The Lancet, 2017. doi.org/10.1016/S0140-6736(18)32281-5

• 2014 – Oral Presenter Award, 15^th Annual Medical Students Congress, Shahrood, Iran
• 2014 – Travel grant, 10^th International Diabetes Federation-Western Pacific Region Conference, Singapore
• 2014 – Student Research Grant, Shahed University of Medical Sciences, Deputy of Research, Tehran, Iran
• 2017 – Top Reviewer for Multidisciplinary, Web of Science - ISI
• 2018 – Travel Grant, International Congress of Diabetes and Metabolism (ICDM-2018) Seoul, South Korea
• 2023 – Abstract Award, IDWeek 2023, Boston, MA
• 2024 – Mentee Award, IDWeek 2024, Los Angeles, CA
• 2026 – Abstract Award, IDWeek 2026, Washington DC

• 2016 – 2018:  Executive Manager of Hepatitis Awareness Campaigns in Iran
• 2018:  Viral hepatitis and HIV screening and HBV immunization program for working children of Afghan immigrants in two supporting centers in Tehran and Alborz province. doi.org/10.5812/pedinfect.86118
• 2022 – 2024:  Facilitated the integration of hepatitis C testing and treatment into the REACH and Man Alive opioid treatment programs in Baltimore, Maryland, including conducting study follow-up visits with participants and training and supervising peer navigators with lived experience.

Volunteer Research Activities

• 2015 – Current:  Over 400 peer-review and editorship records for the international clinical journals available at Web of Science: https://www.webofscience.com/wos/author/record/B-5691-2017
• 2017 – 2025:  Associate Editor, Hepatitis Monthly Journal (Scopus, ISI)
• 2020 – 2022:  Academic Editor, Advances in Public Health Journal (Scopus, ISI)
• 2021 – Current:  Academic Editor, PLOS ONE Journal